Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06647589 · ClinicalTrials.gov registry record · NA

Acceptance and Commitment Therapy for Religious OCD

A NA study of Obsessive Compulsive Disorder (OCD), sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06647589 is a NA study of Obsessive Compulsive Disorder (OCD) that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants, below the 243-participant average among 12 other Obsessive Compulsive Disorder (OCD) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06647589, a NA study of Obsessive Compulsive Disorder (OCD), is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-07-30
Est. Completion 2026-09-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06647589

The ClinicalTrials.gov registry entry for NCT06647589 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 243-participant average among 12 other Obsessive Compulsive Disorder (OCD) trials with a reported enrollment target (96% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive Compulsive Disorder (OCD) appearing as the primary indexed condition, and to 1 intervention - of which Acceptance and Commitment Therapy is the first listed.

NCT06647589 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06647589 about?

NCT06647589 is a clinical study titled "Acceptance and Commitment Therapy for Religious OCD". The purpose of the study is to examine the effects and feasibility of a specific form of psychotherapy, acceptance and commitment therapy (ACT), on religiously oriented obsessive and compulsive disorder (OCD).

What is the current status of trial NCT06647589?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-07-30. Estimated completion is 2026-09-01.

What conditions does trial NCT06647589 study?

This clinical trial studies the following conditions: Obsessive Compulsive Disorder (OCD).

What interventions are being tested in trial NCT06647589?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06647589?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06647589 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive Compulsive Disorder (OCD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.